2025. A Scaffold-Aware Machine Learning Docking Pipeline for TYK2 Inhibitor Discovery with Calibrated Prioritization of 32 Active Compounds Including Deucravacitinib. International Research Journal of Management and Social Sciences. 6, 4 (Dec. 2025), 42–55.